Arotinoid mofarotene (RO40-8757) up-regulates p21 and p27 during growth inhibition of pancreatic cancer cell lines

This publication has 16 references indexed in Scilit:

• Antiproliferative effects of the arotinoid Ro 40-8757 in human gastrointestinal and pancreatic cancer cell lines: combinations with 5-fluorouracil and interferon-α
  British Journal of Cancer, 1996
• Inhibitory effect of 220-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines
  Gastroenterology, 1996
• All-trans-Retinoic Acid Inhibits Growth of Human Pancreatic Cancer Cell Lines
  Pancreas, 1996
• Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.
  Genes & Development, 1996
• The RXR heterodimers and orphan receptors
  Published by Elsevier ,1995
• Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
  Nature Genetics, 1994
• 13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix
  JNCI Journal of the National Cancer Institute, 1992
• 13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin
  JNCI Journal of the National Cancer Institute, 1992
• The E2F transcription factor is a cellular target for the RB protein
  Cell, 1991
• Ligand specificities of recombinant retinoic acid receptors RAR α and RAR β
  Biochemical Journal, 1990